Vincristine sulfate treatment influence on kidney function of female dogs with transmissible venereal tumor




Chemotherapy, Gamma-glutamyl transferase, Renal injury, Renal marker, Symmetric dimethylarginine


Chemotherapy agents have some undesirable and non-selective cytostatic effects. Considering that kidneys are vulnerable to drug-induced toxicity, this study evaluated renal injury caused by vincristine sulfate (VS) in 12 female dogs diagnosed with transmissible venereal tumor (TVT). The animals were treated with VS (0.025 mg/kg IV) every 7 days for 4 weeks. During treatment, the animals were subjected to clinical examination, blood count, serum measurement of symmetric dimethylarginine (SDMA), blood urea nitrogen (BUN), creatinine, alanine aminotransferase, and alkaline phosphatase. In addition, urinalysis and urinary gamma-glutamyl transferase (GGT) measurements were performed. All parameters were determined three times: before beginning the treatment (T0), after 14 days (T1), and after 28 days (T2). During the study period, there were no changes in serum urea or creatinine levels, urine specific gravity, or persistent proteinuria. Furthermore, urinary GGT measurement did not indicate tubular lesions, and consistent elevation of SDMA was found in only one patient above the reference range. The results showed that weekly therapy with VS as a single agent for 28 days does not induce renal injury in most cases.


Download data is not yet available.


Abrams-Ogg A, Rutland B, Levis P, Sabine V, Majeed A, Bienzle D, Linden AZ, Richardson D, Mutsaers A, Woods P. Lymphoma and symmetric dimethylarginine concentration in dogs: a preliminary study. J Vet Intern Med. 2017;31(5):1584-5.

Braz PH, Marinho CP. Comparison between hematological and biochemical changes caused by conventional and metronomic chemotherapies in the treatment of canine transmissible venereal tumor. Pesq Vet Bras. 2021;41:e06575.

Cardozo RM, Reis R, Barbosa MJB, Alcalá COR, Assis MF. Avaliação hematológica em cães errantes da região urbana de Maringá-PR. Pubvet. 2013;7(26):1-8.

Cianciolo R, Hokamp J, Nabity M. Advances in the evaluation of canine renal disease. Vet J. 2016;215:21-9. http://dx.doi. org/10.1016/j.tvjl.2016.04.012. PMid:27198066.

Crivellenti LZ, Mesa JS, Meirelles AÉ, Borin Crivellenti S, Mireya EG, Canola JC, Hatayde MR, Santana AE, Dantas M, Silva GE. False positivity of gamma-glutamyl transpeptidase measurement in urine. Ren Fail. 2014;36(4):581-4. PMid:24456228.

Furini AAC, Guimarães PM, Silva FS, Lopes MASM, Castro KF, Atique TSC, Netto HA. Estudo da variação neutropênica pelo sulfato de vincristina em cães com TVT tratados em um hospital veterinário do noroeste paulista, Umuarama. Arquivos Ciênc Vet Zool. 2014;17(1):5-9.

Ganguly B, Das U, Das AK. Canine transmissible venereal tumour: a review. Vet Comp Oncol. 2016;14(1):1-12. PMid:23981098.

Grigorian A, O’Brien CB. Hepatotoxicity secondary to chemotherapy. J Clin Transl Hepatol. 2014;2(2):95-102. PMid:26357620.

Hall JA, Yerramilli M, Obare E, Yerramilli M, Jewell DE. Comparison of serum concentrations of symmetric dimethylarginine and creatinine as kidney function biomarkers in cats with chronic kidney disease. J Vet Intern Med. 2014;28(6):1676-83. PMid:25231385.

Hantrakul S, Klangkaew N, Kunakornsawat S, Tansatit T, Poapolathep A, Kumagai S, Poapolathep S. Clinical pharmacokinetics and effects of vincristine sulfate in dogs with transmissible venereal tumor (TVT). J Vet Med Sci. 2014;76(12):1549-53. PMid:25649934.

Kanca H, Tez G, Bal K, Ozen D, Alcigir E, Atalay Vural S. Intratumoral recombinant human interferon alpha-2a and vincristine combination therapy in canine transmissible venereal tumour. Vet Med Sci. 2018;4(4):364-72. PMid:30117719.

Kopke MA, Burchell RK, Ruaux CG, Burton SE, LopezVillalobos N, Gal A. Variability of symmetric dimethylarginine in apparently healthy dogs. J Vet Intern Med. 2018;32(2):736- 42. PMid:29469955.

Kumar VVVA, Kumari KN, Kumar KS, Kumar VG, Lakshman M. Effect of Vincristine chemotherapy in TVT affected dogs. The Pharma Innovation Journal. 2018;7(4):163-6.

López-Gómez L, Díaz-Ruano S, Girón R, López-Pérez AE, Vera G, Herradón Pliego E, López-Miranda V, Nurgali K, Martín-Fontelles MI, Uranga JA, Abalo R. Preclinical evaluation of the effects on the gastrointestinal tract of the antineoplastic drug vincristine repeatedly administered to rats. Neurogastroenterol Motil. 2018;30(11):e13399. PMid:29971865.

Lucas GNC, Leitão ACC, Alencar RL, Xavier RMF, Daher EF, Silva GBD Jr. Pathophysiological aspects of nephropathy caused by non-steroidal anti-inflammatory drugs. J Bras Nefrol. 2019;41(1):124-30. PMid:30281062.

Nabity MB, Lees GE, Boggess MM, Yerramilli M, Obare E, Yerramilli M, Rakitin A, Aguiar J, Relford R. Symmetric dimethylarginine assay validation, stability, and evaluation as a marker for the early detection of chronic kidney disease in dogs. J Vet Intern Med. 2015;29(4):1036-44. PMid:26079532.

O’Keefe DA, Harris CL. Toxicology of oncologic drugs. Vet Clin North Am Small Anim Pract. 1990;20(2):483- 504. PMid:2180191.

Perondi F, Lippi I, Ceccherini G, Marchetti V, Guidi G. Evaluation of urinary γ-glutamyl transferase and serum creatinine in non-azotaemic hospitalised dogs. Vet Rec. 2019;185(2):52. PMid:31076519.

Piscitani L, Sirolli V, Di Liberato L, Morroni M, Bonomini M. Nephrotoxicity associated with novel anticancer agents (aflibercept, dasatinib, nivolumab): case series and nephrological considerations. Int J Mol Sci. 2020;21(14):4878. PMid:32664269.

Priyadarshini N, Das DP, Panda SK, Samal L. Transmissible venereal tumours (TVT) in bitches: a haematological, biochemical and histopathological study. J Entomol Zool Stud. 2021;9(1):490-3.

Priyadarshini N, Das DP, Panda SK, Samal L. Transmissible venereal tumours (TVT) in bitches: a haematological, biochemical and histopathological study. J Entomol Zool Stud. 2021;9(1):490-3.

Reynolds SB, Hashmi H, Ngo P, Kloecker G. Rescue therapy for acute idiopathic thrombocytopenic purpura unresponsive to conventional treatment. BMJ Case Rep. 2019;12(1):bcr-2018-227717. PMid:30642865.

Sajjad H. Study of nephrotoxic effects of vincristine-treatment in mice. Ann Biol Res. 2012;3(5):2304-6.

Shati AA. Sub-chronic administration of vincristine sulphate induces renal damage and apoptosis in rats via induction of oxidative stress and activation of Raf1-MEK1/2- Erk1/2 signal transduction. Int J Morphol. 2019;37(1):273-83.

Smee NM, Pohlman LM, Vahl C, et al. Effect of storage time and temperature on canine urine enzymes N-acetyl-βD-glucosaminidase (NAG) and γ-glutamyl transpeptidase (GGT). Int J Appl Res Vet Med. 2016;14(1):114-21.




How to Cite

Souza, J. V. de A. ., Gonçalves, F. D. M., Lira-Junior, A. C. O. G., Escodro, P. B. ., Câmara, D. R., & Notomi, M. K. (2022). Vincristine sulfate treatment influence on kidney function of female dogs with transmissible venereal tumor. Brazilian Journal of Veterinary Research and Animal Science, 59, e192646.




Most read articles by the same author(s)